Cargando…
Direct Reprogramming—The Future of Cardiac Regeneration?
Today, the only available curative therapy for end stage congestive heart failure (CHF) is heart transplantation. This therapeutic option is strongly limited by declining numbers of available donor hearts and by restricted long-term performance of the transplanted graft. The disastrous prognosis for...
Autores principales: | Doppler, Stefanie A., Deutsch, Marcus-André, Lange, Rüdiger, Krane, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581198/ https://www.ncbi.nlm.nih.gov/pubmed/26230692 http://dx.doi.org/10.3390/ijms160817368 |
Ejemplares similares
-
Genome Editing Redefines Precision Medicine in the Cardiovascular Field
por: Dzilic, Elda, et al.
Publicado: (2018) -
Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
por: Lahm, Harald, et al.
Publicado: (2015) -
Detection of Intracellular Gene Expression in Live Cells of Murine, Human and Porcine Origin Using Fluorescence-labeled Nanoparticles
por: Lahm, Harald, et al.
Publicado: (2015) -
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration
por: Chen, Olivia, et al.
Publicado: (2015) -
Cardiac regeneration by direct reprogramming in this decade and beyond
por: Yamakawa, Hiroyuki, et al.
Publicado: (2021)